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Abstract
Background: The 2009 A/H1N1 influenza pandemic has received a great deal of attention from public health authorities.
Our study examines whether this pandemic and the resulting public health measures could have impacted acute diarrhea, a
prevalent, highly transmissible and historically monitored disease.
Methods: Using augmentation procedures of national data for the previous five years (2004–2009), we estimated the
expected timing and incidence of acute diarrhea in France in 2009–2010 and evaluated differences with the observed. We
also reviewed national hand gels for the same period.
Findings: Number of episodes of acute diarrhea in France in 2009–2010 was significantly lower than expected until the third
week of December (224%, 95% CI [236%; 29%]), then significantly higher (+40%, 95% CI [22%; 62%]), leading to a surplus
of 574,440 episodes. The epidemic was delayed by 5 weeks with a peak 1.3 times higher than expected. Hand-gels sales
inversely correlated with incidence of both influenza-like illness and acute diarrheal disease. Among individuals .65 yo, no
excess cases of influenza and no excess rebound in acute diarrhea were observed, despite similar delay in the onset of the
seasonal diarrheal epidemic.
Interpretation: Our results suggest that at least one endemic disease had an unexpected behavior in 2009–2010. Acute
diarrhea seems to have been controlled during the beginning of the pandemic in all age groups, but later peaked higher
than expected in the younger population. The all-age delay in seasonal onset seems partly attributable to hand-gels use,
while the differential magnitude of the seasonal epidemic between young and old, concurrent for both influenza and acute
diarrhea, is compatible with disease interaction.
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Introduction
The first cases related to a novel strain of Influenza A/H1N1
appeared in Mexico within the first months of 2009, resulting in
the first influenza pandemic of the 21st century [1]. During the
international crisis that followed, a number of containment
measures were taken at the national [2,3] and international levels
[4]. While some measures were specific to influenza (e.g. mass
vaccinations campaigns, recommended by WHO and initiated in
October 2009 in many countries including France [5]), a number
of non-pharmaceutical measures able to impact communicable
disease transmission generally were also variably recommended
across communities: restrictions on mass transport services and
nonessential travels [4], social distancing interventions (closing
schools and workplaces and limiting public gatherings) [4,6], and
avoiding contact with the sick. At the national level, the most
universally recommended two-set measures were frequent hand-
washing and availability and use of alcohol-based hand sanitizers;
as well as covering sneezes/coughs, and the use of masks, all
widely advocated through extensive print, audio, video campaigns
conducted throughout virtually all public spaces, airwaves and
outlets. Recent theoretical models confirm the legitimacy of these
early, sustained, and non-pharmaceutical interventions for influ-
enza containment[7–12]. However, there is a severely lacking
amount of information about the potential indirect impact of this
international crisis on other prevalent diseases. The aim of this
study was to take advantage of the unique natural experiment of
large-scale multi-focal public health interventions and to assess
their impact on a historically monitored commonly transmitted
infectious disease.
Methods
We hypothesized that the collateral effect of the previously
described large-scale interventions would reduce transmission of
acute diarrheal disease in France.
Acute gastro-enteritis was chosen because it is among the most
common illnesses worldwide, with more than 4.5 M cases in
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France in 2011 (data from French Sentinelles Network). It is also
highly transmissible with two main etiologic agents, rotavirus for
children,2 years and Norovirus for adults [13], requiring small
infectious doses [14].
Our analysis is based on syndromic data from the Sentinelles
network database [15–17]. Sentinelles is a network of 1300
volunteer general practitioners working in metropolitan regions
throughout France (see http://www.sentiweb.org/). They contin-
uously report cases of eight different diseases. In particular, the
database includes weekly reports of influenza like illness since 1984
and of acute diarrhea cases since 1990. A case of syndromic acute
diarrhea was defined as a patient having at least three daily, soft or
watery stools in the past 14 days. In order to analyze influenza
incidence in France, we used the estimated number of Influenza-
like illness cases (ILI, defined as patients with sudden fever .39uC
with myalgia and respiratory signs) reported by the same network.
This database has recently been used to show the impact of school
closures –another kind of preventive measure– on influenza
epidemic [17]. We acknowledge that ILI is a poor estimator of true
influenza incidence. However, we are more interested in this study
by the timing of the epidemic and by yearly comparisons than by
the true level of influenza incidence.
We then estimated the expected weekly incidence, or number of
cases, of acute diarrhea, and influenza during the 2009–2010
period. Data augmentation procedures (bootstrapping) were used
to generate 1000 new datasets of weekly incidence, or number of
cases, based on the five previous years (2004–2009). A 5% random
noise was added to the data to account for potential inaccuracy in
data collection. Thanks to this method we were able to compute a
weekly average incidence and 95% bootstrap confidence intervals.
Data interpolation was performed using a sliding average to
remove noise in the data and highlight the general trend. This
simple approach can be qualified as a non-adaptive version of the
‘‘analogues method’’ previously used on similar data [18], i.e. based
on the basic premise that an epidemic is likely to behave as
previous ones. To validate the method we estimated the 2008–
2009 ‘‘normal’’ season of acute diarrhea epidemic using preceding
years.
Observed and expected 2009/2010 values of incidence rates,
number of cases, time taken to reach epidemic peak, and peak
height were compared. The epidemic period was determined using
the Serfling method [19].The Serfling method uses cyclic
regression to model seasonal pattern of incidence and to define
epidemic threshold. We also conducted separate analysis for the
.65years-old.
We chose to analyze alcohol-based hand gels because of their
sustained recommendation at the national level, and their
potential to interfere with fecal-oral transmission via chemical
cleansing of the hands. Analysis of the evolution of hand gels sales
in France is based on data from a stratified sample of 3004
pharmacies on the French metropolitan territory set up by the
company Celtipharm [20]. These pharmacies automatically report
their sales continuously several times a day since 2007. Thanks to a
regularly updated exhaustive database of the 22,458 active French
pharmacies, a stratification to improve representativeness is
performed on sales revenue (6 levels for global revenue and 4
levels per type of sales: prescribed drugs, OTC, and other type of
sales), localization (5 geographic areas) and sales area (5 types,
from rural to densely urban). Each stratum has a minimum of 30
pharmacies or is merged with neighboring strata. Sampling rates
per strata are computed with the Neyman optimal allocation
algorithm [21]. Extrapolations from the sample have been
validated with data from drug manufacturers who distribute their
products directly (and only) to pharmacies.
Results
The 2009 influenza pandemic in France was different from
previous seasonal influenza epidemics, both in timing and
magnitude (Figure 1). The epidemic started in July 2009, with a
peak in the middle of November, and ended in January 2010. In
previous years (2004 to 2009), the epidemic lasted from November
to April, with a peak in January (Figure S1). The 2009 epidemic
peak was also higher than during previous seasonal influenza
epidemics.
In 2009–2010, the number of acute diarrhea episodes in France
was significantly lower than expected until the third week of
December (224%; 95% CI: 236%, 29%), and then significantly
higher (+40%; 95% CI: 22%, 62%), leading to an excess of
574,440 episodes (+14%; 95% CI: 22%,+34%) (Table 1). As
shown in Figure 2, the epidemic started the second week of
December and was delayed by five weeks; the maximum incidence
occurred during the first week of January, one week later than
expected, with the peak 1.3 times higher. Details of the differences
between estimated and observed incidence are in Table 1. Figure 3
and S2 show that the beginning of the acute diarrhea epidemic in
previous years (2004–2009) was observed 3 weeks before the
beginning of the influenza epidemic, with an epidemic peak one
month before the peak of influenza. In 2009–2010, however, the
acute diarrhea epidemic started right at the end of the influenza
epidemic, with a peak six weeks after the peak of influenza.
Estimations of the 2008–2009 ‘‘normal season’’ using the same
method based on 2004–2008 years or using a larger dataset (2000–
2008) were consistent with observations (start and peak of the
epidemic in the 95% confidence interval, see figures S3 and S4 for
details).
Because the 2009–2010 Influenza A/H1N1 primarily affected
the young, sparing the old, we decided to separate the .65 years-
old to determine whether both the delay in onset and the higher
magnitude rebound were observed in this age group. While the
onset of the acute diarrhea seasonal epidemic was delayed, no
excessive rebound was observed among older subjects (Figure 2b):
the number of episodes in 2009/2010 was significantly lower than
expected until the last week of December (219%; 95% CI:225%,
28%), a deficit which was never recouped, leading to an overall
reduction of 11% in the total number of cases.
Sales of hand gels peaked just before and during the very early
beginning of the influenza epidemic but plummeted right before
the real beginning of the epidemic peak (Figure 4). In addition, the
Figure 1. Incidences of influenza-like illness in 2009–2010 for
France. Observed incidences are shown with black lines while
expected incidences are shown with gray lines along their 95%
confidence interval in dashed lines. Expected incidence is based on
2004–2009 data. The comparison shows the pandemic arrived sooner
than previous years. The plot show smoothed data.
doi:10.1371/journal.pone.0075226.g001
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acute diarrhea epidemic started when the sales were at their lowest
level. Of note, we also observe no hand-gels sales increase during
the two epidemic seasons (2007–2008, 2008–2009) preceding the
pandemic and the one following it (2010–2011) (Figure 4).
Discussion
We report unusual incidence patterns of acute diarrhea
associated with the 2009–2010 influenza A/H1N1 pandemic
and accompanying public health measures in France. Although we
postulated a positive impact of non-pharmaceutical measures
(notably alcohol-based hand-gels) on this communicable disease,
the dramatic rebound in number of cases after the pandemic crisis
was surprising. Our estimates translate into a 24% decrease in the
number of acute diarrhea during the influenza pandemic followed
by a 40% increase afterwards, which corresponded to more than
570,000 additional diarrheal cases compared to previous years.
Thus, overall, we observed two phases: a disease control period
during the influenza pandemic peak (translating into a delayed
onset), then an epidemic rebound afterwards (translating into a
higher peak magnitude). Regarding the first phase, at least two
hypotheses can be offered. First, non-pharmaceutical interventions
such as hand-gels may have had an impact on other communi-
cable diseases transmitted by inter-individual contacts, thereby
controlling acute diarrhea. Second, and perhaps concomitantly,
competition between infections could have occurred, in which
people already affected by influenza were more likely to reduce
their contacts, hence affecting the pool of susceptibles for other
communicable diseases. Consequently, the rebounding second
stage may have coincided with a letdown in the preventive
Table 1. Comparison between 2009–2010 observed acute diarrhea incidence and the expected incidence estimated from
previous years (2004–2009) in France.
Differences with 2009–2010 incidence low incidence expected incidence high incidence
Period between weeks 44 and 52 Incidence (/100 000) 2209 2608 21,104
Number of cases 2134,124 2391,297 2710,282
% of increase or decrease 29% 224% 236%
Period between weeks 53 and 18 Incidence (/100 000) +2,019 +1, 501 +935
Number of cases +1,298,442 +965,737 +601,107
% of increase or decrease +62% +40% +22%
Entire studied period between
weeks 44 and 18
Incidence (/100 000) +1,810 +893 2170
Number of cases +1,164,318 +574,440 2109,175
% of increase or decrease +34% +14.1% 22%
Low and high incidence scenarios are given by the bound of bootstrapped 95% confidence interval. The studied period is divided in two sub-periods, before and after
the week 52 when the observed and expected incidences intersect.
doi:10.1371/journal.pone.0075226.t001
Figure 2. Incidences of acute diarrhea in France in 2009–2010. a) Observed incidence of acute diarrhea in general population (black line)
peaks later and higher than the corresponding expected incidence (gray line, 95% confidence interval shown in dashed lines). b) In patients .65
years old, the peak is also delayed but its maximum is lower than expected. The interval shown at the bottom of the plots stands for the pandemic
period in France defined by the Serfling method. Both plots show smoothed data.
doi:10.1371/journal.pone.0075226.g002
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Figure 3. Comparison between influenza (gray line) and acute diarrhea (black line) incidence patterns in France. a) Observed incidences
in 2009–2010 show that influenza epidemic preceded the acute diarrhea epidemic. During the preceding years the acute diarrhea epidemic was
arriving first, as shown on b) with the expected incidences based on 2004–2009 data. Both plots show smoothed data.
doi:10.1371/journal.pone.0075226.g003
Figure 4. Weekly incidences of acute diarrhea and influenza-like-illness, along with weekly sales of hand gels in France from
January 2008 to March 2011. We observe inverse correlations between sales of hand-gels, and incidence of influenza-like-illness and acute
diarrhea. We also observe no hand-gels sales increase during the two epidemic seasons (2007–2008, 2008–2009) preceding the pandemic and the
one following it (2010–2011).
doi:10.1371/journal.pone.0075226.g004
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measures that were used in the first stage. An increased seasonal
effect could also explain the higher magnitude of the later acute
diarrhea epidemic: the epidemic arriving later in the winter season
may have benefited from a higher impact of the weather on the
force of infection (lower temperature, higher precipitation, etc…).
Alternatively, however, the population may have also been
weakened by the influenza pandemic since this particular strain
has been shown to trigger impaired immune response which may
result in higher susceptibility [22]. However data from our
surveillance network show that the influenza incidence rate in
subjects 65 years and older was no different than in previous years
[23]. In addition it seems that aged individuals developed a milder
form of the disease compared to previous years and contrary to the
younger population [24]. This population is critical in differenti-
ating the impact of universally recommended public health
measures from inter-disease interaction. Indeed, subjects older
than 65 years old in France only experienced the delayed onset
(potentially consistent with increased hand-gels use), but not the
higher-than-expected rebounding stage in acute diarrheal disease.
This discrepancy between delay with no higher magnitude,
specific to that age group less affected than the younger
population, could reveal a link between these two diseases in the
young population, beyond a let down of public health measures.
Not being as affected as the younger, the older population had no
acute diarrhea rebound. The interrelated nature of diseases has
been proposed several times [25–27] to explain for example the
relationship between the 1918 influenza pandemic and declining
death rates of tuberculosis, cardiovascular disease and nephritis in
the US [28,29]. Here, excess cases of acute diarrhea could be
explained as a ‘‘temporary harvesting effect’’ triggered by the
influenza pandemic. All the above could fit diseases interaction
models of syndemics [30] or pathocenosis [31], defined as the idea
of complete interaction between diseases in an interrelated
ecosystem.
Reporting bias could also have affected our data. An
underreporting of acute diarrhea during the influenza pandemic
could explain the sharp increase in the number of cases after the
crisis. Furthermore, differential diagnosis could have been a major
issue considering 38% of patients with influenza A/H1N1
presented with symptoms of nausea and diarrhea [32]. An
alternative explanation could be the priorities, explicit or implicit,
in which diseases were given treatment during the pandemic. In
contrast, an over-reporting of acute diarrhea after the pandemic
could partly explain the higher observed peak. For example, an
increase in care seeking behavior may have occurred after the
pandemic. However, these biases could explain some amplitude
variations but not the observed epidemic delay of 6 weeks nor is
there any easily identifiable reason why they would have spared
the .65 years-old, all the more vulnerable to diarrhea-induced
dehydration.
Hand gel sales analysis may present different bias. First, we
don’t know whether people who bought hand gels effectively used
it. Health seeking behaviors vary by demographic, social and
economic factors. Population consulting a general practitioner and
buying health products may differ. Moreover, it is difficult to link a
number of hand gel sales to a number of patients. However, the
sales analysis is useful to determine temporal evolution and to
detect abnormal phenomena.
Conclusion
Our results tend to show that the 2009–2010 acute diarrhea
epidemic has been delayed compared with previous years. This
delay is temporally associated with a peak of hand-gel sales, which
could be a proxy for other control measures, and with the
influenza pandemic peak. However, the nature of their associa-
tions is still unclear since it could be causal, or simply fortuitous.
But the temporal proximity, the social or possibly biological
arguments emphasize the need for further studies to clarify the
nature of the link. Its existence would highlight the complexity of
predicting the behavior of an epidemic without consideration to
the ecological niche since delaying an epidemic may not imply
decreasing the number of cases.
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Figure S1 Incidences of influenza-like illness in 2009–
2010 and in the previous year (2004–2009) for France.
Observed incidences of influenza in 2009–2010 (black lines)
arrived sooner than previous years. The plot shows smoothed data.
(PDF)
Figure S2 Incidences of acute diarrhea in 2009–2010
and in the previous year (2004–2009) in France. Observed
incidence of acute diarrhea in 2009–2010 (black line) peaks later
and higher than the incidence from previous years. The plot shows
smoothed data.
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Figure S3 Incidences of acute diarrhea in 2008–2009 for
France. Observed incidences are shown with black lines while
expected incidences are shown with gray lines along their 95%
confidence interval in dashed lines. Expected incidence are based
on 2000–2008 data. The comparison shows that estimations of the
2008–2009 incidences are consistent with observations. The plot
shows smoothed data.
(PDF)
Figure S4 Incidences of acute diarrhea in 2008–2009 for
France. Observed incidences are shown with black lines while
expected incidences are shown with gray lines along their 95%
confidence interval in dashed lines. Expected incidences are based
on 2004–2008 data. The comparison shows that estimations of the




The authors thank Celtipharm for graciously providing access to their
pharmaceutical sales data (Xpr-SO).
Author Contributions
Conceived and designed the experiments: PC MD. Performed the
experiments: PC MP. Analyzed the data: PC MP MD. Contributed
reagents/materials/analysis tools: PC MP. Wrote the paper: PC MP MD.
References
1. World Health Organization (n.d.) Pandemic (H1N1) 2009 - Updates. Available:
http://www.who.int/csr/don/2009_04_24/en/index.html.
2. Secre´tariat Ge´ne´ral de la De´fense Nationale (2009) Plan national de prevention
et de lutte ‘‘Pande´mie grippale.’’
3. US Department of Health and Human Services (2005) HHS Pandemic
Influenza Plan.
Impact of A/H1N1 and Hand-Gels on Acute Diarrhea
PLOS ONE | www.plosone.org 5 October 2013 | Volume 8 | Issue 10 | e75226
4. World Health Organization (2009) Pandemic influenza preparedness and
response. Available: http://www.who.int/influenza/resources/documents/
pandemic_guidance_04_2009/en/index.html.
5. World Health Organization (n.d.) WHO recommendations on pandemic
(H1N1) 2009 vaccines. Available: http://www.who.int/csr/disease/.
6. Wu JT, Cowling BJ, Lau EHY, Ip DKM, Ho L-M, et al. (2010) School Closure
and Mitigation of Pandemic (H1N1) 2009, Hong Kong. Emerging Infectious
Diseases 16: 10–13.
7. Glass RJ, Glass LM, Beyeler WE, Min HJ (2006) Targeted social distancing
design for pandemic influenza. Emerging infectious diseases 12: 1671–1681.
8. Germann TC, Kadau K, Longini IM, Macken CA (2006) Mitigation strategies
for pandemic influenza in the United States. Proceedings of the National
Academy of Sciences of the United States of America 103: 5935–5940.
9. Longini IM, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, et al. (2005)
Containing Pandemic Influenza at the Source: Supporting Online Material.
Population (English Edition).
10. Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, et al. (2006)
Strategies for mitigating an influenza pandemic. Nature 442: 448–452.
11. Ferguson NM, Cummings DA, Cauchemez S, Fraser C, Riley S, et al. (2005)
Strategies for containing an emerging influenza pandemic in Southeast Asia.
Nature 437: 209–214.
12. Kelso JK, Milne GJ, Kelly H (2009) Simulation suggests that rapid activation of
social distancing can arrest epidemic development due to a novel strain of
influenza. BMC public health 9: 117.
13. Anderson EJ, Weber SG (2004) Review Rotavirus infection in adults. The
Lancet 4: 91–99.
14. Glass RI, Parashar UD, Bresee JS, Turcios R, Fischer TK, et al. (2006)
Rotavirus vaccines: current prospects and future challenges. Lancet 368: 323–
332.
15. Valleron A-J, Bouvet E, Garnerin P, Me´nare`s J, Heard I, et al. (1986) A
computer network for the surveillance of communicable diseases: the French
experiment. American journal of public health 76: 1289–1292.
16. Flahault A, Blanchon T, Dorle´ans Y, Toubiana L, Vibert JF, et al. (2006) Virtual
surveillance of communicable diseases: a 20-year experience in France.
Statistical methods in medical research 15: 413–421.
17. Cauchemez S, Valleron A-J, Boe¨lle P-Y, Flahault A, Ferguson NM (2008)
Estimating the impact of school closure on influenza transmission from Sentinel
data. Nature 452: 750–754.
18. Viboud C (2003) Prediction of the Spread of Influenza Epidemics by the Method
of Analogues. American Journal of Epidemiology 158: 996–1006.
19. Serfling RE (1963) Methods for current statistical analysis of excess pneumonia-
influenza deaths. Public health reports 78: 494–506.
20. Celtipharm (n.d.) Panel Xpr-SO (c). Available: http://www.xpr-so.com/pages/
Public/Accueil.aspx. Accessed 1 November 2011.
21. Kish JL (1965) Survey Sampling. Wiley & Sons.
22. Fox A, Hoa LNM, Horby P, Van Doorn HR, Trung NV, et al. (2012) Severe
Pandemic H1N1 2009 Infection Is Associated with Transient NK and T
Deficiency and Aberrant CD8 Responses. PloS one 7: e31535.
23. Weil-Olivier C (2010) [First season of pandemic influenza A/H1N1]. La Revue
du praticien 60: 1388–1391, 1394–1398.
24. Lemaitre M, Carrat F, Rey G, Miller M, Simonsen L, et al. (2012) Mortality
burden of the 2009 A/H1N1 influenza pandemic in France: comparison to
seasonal influenza and the A/H3N2 pandemic. PloS one 7: e45051.
25. McNeill WH (1998) Plagues and peoples. Anchor Books.
26. Crosby AW (2003) The Columbian exchange: biological and cultural
consequences of 1492. Greenwood Publishing Group.
27. Noymer A (2010) Epidemics and Time, Influenza and Tuberculosis during and
after the 1918–1919 Pandemic. Plagues and Epidemics: Infected Spaces Past
and Present. 137–152.
28. Noymer A, Garenne M (2000) The 1918 influenza epidemic’s effects on sex
differentials in mortality in the United States. Population and Development
Review.
29. Garenne M, Noymer A (2008) Les effets a` long terme de la grippe espagnole de
1918. Cahiers de sociologie et de de´mographie me´dicales.
30. Singer M, Clair S (2003) Syndemics and public health: reconceptualizing disease
in bio-social context. Medical anthropology quarterly 17: 423–441.
31. Grmek MD (1969) Pre´liminaires d’une e´tude historique des maladies. Annales
Histoire, Sciences Sociales 24: 1473–1483.
32. Team NS-OIA (H1N1) VI (2009) Emergence of a Novel Swine-Origin Influenza
A (H1N1) Virus in Humans. The New England journal of medicine 360: 2605–
2615.
Impact of A/H1N1 and Hand-Gels on Acute Diarrhea
PLOS ONE | www.plosone.org 6 October 2013 | Volume 8 | Issue 10 | e75226
